Nasdaq IPOs

Latest SPAC: Eklavya Saraf, Nasdaq’s global head of SPAC listings, goes behind Friday morning’s virtual Nasdaq Opening Bell, sharing his insight on how DraftKings tapped the public markets.

Lyra Therapeutics, a Phase 2 biotech developing an implantable drug matrix for chronic rhinosinusitis, announced terms for its IPO on Monday. The Watertown, MA-based company plans to raise $53 million by offering 3.5 million shares at a price range of $14 to $16. At the midpoint

GAN Limited, a UK-based provider of internet gambling software, announced terms for its IPO on Monday. The London, United Kingdom-based company plans to raise $30 million by offering 4.1 million shares at a price range of $6.50 to $8.50. At the midpoint of the proposed range, GAN

Updated on 4/27/2020. One biotech is on the calendar for the week ahead. The IPO market is showing some early signs of opening up. Recent biotech IPOs have had strong debuts, SPAC activity has picked up, and a few deals in the pipeline like Albertsons (ACI) and Kingsoft (KC) have

There are no IPOs scheduled for the week ahead, but the IPO market is showing some early signs of opening up. Recent biotech IPOs have had strong debuts, SPAC activity has picked up, and a few deals in the pipeline like Albertsons (ACI) and Kingsoft (KC) have signaled potential M

The IPO market saw a jump in activity as one biotech and three SPACs went public this past week. The durability of the biotech industry was demonstrated once again, with ORIC Pharmaceuticals (ORIC) popping 61% on its first day. Four IPOs and one SPAC submitted initial filings. O

ADC Therapeutics, a Swiss Phase 2 biotech developing next-gen antibody drug conjugates for difficult cancers, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The company filed previously in September 2019 before withdrawing its S1 later in

Ebang International Holdings, which makes equipment for cryptocurrency mining in China, filed on Friday with the SEC to raise up to $100 million in an initial public offering. Ebang designs application-specific integrated circuit (ASIC) chips and fabless integrated circ

The IPO market saw a jump in activity as one biotech and three SPACs went public this past week. The durability of the biotech industry was demonstrated once again, with ORIC Pharmaceuticals (ORIC) popping 61% on its first day. Four companies and one SPAC submitted initial filing

SeqLL, which provides a genetic sequencing platform for researching the makeup of diseases, withdrew its plans for an initial public offering on Friday. It had originally filed in April 2019 to raise $8 million by offering 1.4 million shares at a price range of $5.40 to $6.40. Th

Diamond Eagle Acquisition, the fifth blank check company formed by entertainment veteran Jeff Sagansky, completed its previously-announced acquisition of DraftKings. The newly combined company began trading on the Nasdaq on Friday under the symbol DKNG, with an expected market ca

Chardan Healthcare Acquisition 2, the second blank check company formed by Chardan Capital targeting the healthcare industry, raised $85 million by offering 8.5 million units at $10. Each unit consists of one share of common stock and one warrant, exercisable for one half a share

Skillful Craftsman Education Technology, which provides online education and technology services in China, filed on Friday with the SEC to raise up to $15 million in an initial public offering. The Jiangsu, China-based company plans to raise $15 million by offering 3 million shar

CC Neuberger Principal Holdings I, a blank check company formed by CC Capital and Neuberger Berman, raised $360 million by offering 36 million units at $10. CC Neuberger Principal I originally filed to raise $300 million by offering 30 million units. The company changed its units

ORIC Pharmaceuticals, a Phase 1 biotech developing small molecule therapies for treatment-resistant cancers, raised $120 million in an upsized IPO by offering 7.5 million shares at $16, the high end of the range of $14 to $16. Earlier on Thursday, ORIC announced it would off

Venture firm The Column Group is the lead investor behind this week's IPO, immuno-oncology biotech ORIC Pharmaceuticals (ORIC). Based on the IPO Pro venture screen, it is the fifth IPO exit for Column over the past two years. The San Francisco-based VC focuses on e

B. Riley Principal Merger II, the second blank check company formed by diversified financial services firm B. Riley Financial, filed on Thursday with the SEC to raise up to $200 million in an initial public offering. The New York, NY-based company plans to raise $200 million by o

Fortress Value Acquisition (FVAC.U), a blank check company formed by executives at Fortress Investment Group, amended the terms of its upcoming IPO to be more favorable to new investors. The New York, NY-based company plans to raise $300 million at a $375 million market cap. It o

MingZhu Logistics Holdings, which provides trucking and logistics services in China, reported financial results for the fiscal year 2019 in an amendment filed with the SEC on Thursday. It originally filed for an IPO in September 2019 with a proposed deal size of $13 million.&nbsp

There is no better beacon of light for a path out of the tangled forest created by the Covid-19 virus than the ingenuity of the American people. It’s expressed in businesses large and small quickly transforming themselves into producers of PPE and the overnight migration of